当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Wen Zhang
Currently, thyroid cancer and benign thyroid conditions are both often treated with complete thyroidectomy. It is still debatable how to distinguish between benign and malignant thyroid conditions and whether or not thyroid micro carcinomas may be detected using biochemical markers. The objective of this retrospective study was to assess the predictive value of thyroid autoantibodies, thyroglobulin, and thyroid disease type in diagnostic techniques regarding the co-existence of incidental thyroid cancer with benign thyroid illnesses. Methods. Between 2005 and 2010, 228 individuals with benign thyroid diseases had TT treatment. TG and thyroid autoantibodies were calculated before surgery [1]. The median values of the biochemical markers were compared between the groups after patients were divided into groups based on their preoperative and histologically confirmed diagnosis [2].